[
    "/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00105.TIF\"/>ANDB <img id=\"EMI-C00106\" path=\"US20080234334A1-20080925-C00106.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537039/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00106.TIF\"/>ANDA <img id=\"EMI-C00107\" path=\"US20080234334A1-20080925-C00107.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537102/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00107.TIF\"/>ANDB <img id=\"EMI-C00108\" path=\"US20080234334A1-20080925-C00108.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537076/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00108.TIF\"/>ANDB <img id=\"EMI-C00109\" path=\"US20080234334A1-20080925-C00109.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537014/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00109.TIF\"/>ANDD <img id=\"EMI-C00110\" path=\"US20080234334A1-20080925-C00110.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537117/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00110.TIF\"/>ANDC <img id=\"EMI-C00111\" path=\"US20080234334A1-20080925-C00111.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537130/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00111.TIF\"/>NDNDE <img id=\"EMI-C00112\" path=\"US20080234334A1-20080925-C00112.TIF\" file=\"https://surechembl.org/api/assets/attachment/46537070/US/20080925/A1/020080/23/43/34/US20080234334A1-20080925-C00112.TIF\"/>NDNDELegend:For Rb+ efflux cellular assay: A: EC50 \u2266 1 nM; B: = 1 nM &lt; EC50 \u2266 10 nM; C: 10 nM &lt; EC50 \u2266 50 nM; D: 50 nM &lt; EC50 \u2266 500 nM; E: &gt; 500 nM.For mouse MES test at ip dosing of 12.5 mg/kg: A: active; B: inactive;For rat MES test: A: ED50 &lt; 20 mg/kg; B: ED50 &gt; 20 mg/kg;ND: not determined;</p>Studies of Compound's KCNQ2/3 Opening Activity and KCNQ Subtype Selectivity Using Electrophysiological Patch Clamp in Xenopus oocytes</p>Expression in Xenopus laevis Oocytes</p>Female Xenopus laevis extracted ovaries were purchased from eNASCO (LM00935MX, eNASCO Fort Atkinson, Wis.). Following manual dissection of the oocytes into smaller groups, the oocytes were defolliculated by enzymatic treatment with collagenase type 2 (LS004177, Worthington, Lakewood, N.J.) for 1\u00bd hour in the presence of calcium-free Culture Bath solution (88 mM NaCl, 1 mM KCl, 0.82 mM MgSO<sub>4</sub>, 2.4 mM NaHCO<sub>3</sub>, and 5 mM HEPES, pH 7.5). Oocytes were then kept in supplemented Culture Bath solution (88 mM NaCl, 1 mM KCl, 0.82 mM MgSO<sub>4</sub>, 0.9 mM CaCl<sub>2</sub>, 2.4 mM NaHCO<sub>3</sub>, 1 mM sodium pyruvate, 0.05 mg/ml Geneticin, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 5 mM HEPES, pH 7.5) at 19\u00b0 C. for 24 hours before injection of cRNA. Approximately 50 nl cRNA (about 50 ng) was injected for KCNQ1, KCNQ4, and KCNQ5 using a Nanoject microinjector (Drummond, Broomall, Pa., USA). For co-expression of KCNQ2 and KCNQ3 and of KCNQ1 and KCNE1, cRNA's were mixed in equal molar ratios before injection of approximately 50 nl. The mixtures contained about 10+10 ng and 12.5+2.5 ng cRNA, respectively."
]